FOLATE LEVELS AND NEURAL-TUBE DEFECTS - IMPLICATIONS FOR PREVENTION

被引:575
作者
DALY, LE
KIRKE, PN
MOLLOY, A
WEIR, DG
SCOTT, JM
机构
[1] HLTH RES BOARD,DUBLIN,IRELAND
[2] TRINITY COLL DUBLIN,DEPT CLIN MED,DUBLIN,IRELAND
[3] TRINITY COLL DUBLIN,DEPT BIOCHEM,DUBLIN,IRELAND
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1995年 / 274卷 / 21期
关键词
D O I
10.1001/jama.274.21.1698
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using data from a recent case-control study, a woman's risk of having a child with a neural tube defect (NTD) was found to be associated with early pregnancy red cell folate levels in a continuous dose-response relationship. These findings were used to calculate the reduction in NTD cases that would be expected under two different strategies to raise folate levels. Targeting high-risk individuals has a small effect on the population prevalence but can substantially change an individual's risk. Targeting the population produces a small change in individual risk but has a large effect on the population prevalence. Supplementation of high-risk women would be the most efficient method to implement the high-risk strategy, while food fortification would be preferable for the population approach. The current guidelines for the prevention of NTD are for an increased folio acid intake of 0.4 mg per day. This would result in a 48% reduction in NTDs, which may be near optimal. The two intervention strategies should be considered complementary in prevention of NTDs.
引用
收藏
页码:1698 / 1702
页数:5
相关论文
共 16 条
  • [1] ANNOTATION - HOW DO WE GET ENOUGH FOLIC-ACID TO PREVENT SAME NEURAL-TUBE DEFECTS
    BERESFORD, SAA
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (03) : 348 - 350
  • [2] MINIMAL COMPLIANCE WITH THE DEPARTMENT-OF-HEALTH RECOMMENDATION FOR ROUTINE FOLATE PROPHYLAXIS TO PREVENT FETAL NEURAL-TUBE DEFECTS
    CLARK, NAC
    FISK, NM
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (08): : 709 - 710
  • [3] PREVENTION OF THE 1ST OCCURRENCE OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION
    CZEIZEL, AE
    DUDAS, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (26) : 1832 - 1835
  • [4] HESEKER H, 1987, J NUTR SCI VITAMINOL, V33, P163, DOI 10.3177/jnsv.33.163
  • [5] HUBER AM, 1988, J AM DIET ASSOC, V88, P791
  • [6] A RANDOMIZED TRIAL OF LOW-DOSE FOLIC-ACID TO PREVENT NEURAL-TUBE DEFECTS
    KIRKE, PN
    DALY, LE
    ELWOOD, JH
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (12) : 1442 - 1446
  • [7] DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF FOLATE TREATMENT BEFORE CONCEPTION TO PREVENT RECURRENCE OF NEURAL-TUBE DEFECTS
    LAURENCE, KM
    JAMES, N
    MILLER, MH
    TENNANT, GB
    CAMPBELL, H
    [J]. BRITISH MEDICAL JOURNAL, 1981, 282 (6275) : 1509 - 1511
  • [8] FOLIC-ACID PREVENTABLE SPINA-BIFIDA AND ANENCEPHALY
    OAKLEY, GP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (10): : 1292 - 1293
  • [9] PREVENTION OF NEURAL-TUBE DEFECTS WITH FOLIC-ACID A SUCCESS BUT
    SCOTT, J
    WEIR, DG
    KIRKE, PN
    [J]. QUARTERLY JOURNAL OF MEDICINE, 1994, 87 (12): : 705 - 707
  • [10] SMITHELLS RW, 1983, LANCET, V1, P1027